Search
Welcome
  • Login
  • Register
Forgot Password?
Lost your password? Please enter your username or email address. You will receive a link to create a new password via email.
Not a subscriber? Subscribe here
Register Now
  • Login
  • Register
Forgot Password?
Lost your password? Please enter your username or email address. You will receive a link to create a new password via email.
                       
Careers & Tenders
Newsletters
Subscribe
The Mail & Guardian
      SUBSCRIBE / Support independent journalism                   CAREERS & TENDERS / Visit careers.mg.co.za                   WHATSAPP? / Follow the M&G WhatsApp channel here            
Login / Register

LOGIN

  • News
    • Africa
    • Business
    • Editorial
    • Education
    • Health
    • Motoring
    • National
    • Sci-tech
    • Sport
    • World
  • Thought Leader
  • Politics
  • Green Guardian
  • Friday
  • The Diplomat
  • G20 South Africa
  • Power of Women
  • Events
    • 200 Young South Africans
    • Greening The Future
    • Critical Thinking Forum
    • Youth Summit
    • Webinars
  • More..
    • Research World
    • Partners
    • Podcasts
    • Crossword
    • Digital Editions
    • Register
    • WhatsApp Channel
    • Login
    • Lost Password

           

Hiv/aids

SA’s first batch of LEN jabs will arrive in February. Use Bhekisisa’s dashboard to find out who should get them
Health
/ 2 December 2025

SA’s first batch of LEN jabs will arrive in February. Use Bhekisisa’s dashboard to find out who should get them

Who should get what slice of the pie once the medicine is available in public clinics? And are numbers alone what would drive decisions?

By Linda Pretorius and Jacques Verryn
SA wants to make its own six-monthly HIV prevention jabs by 2027. But there’s a hitch
Health
/ 1 December 2025

SA wants to make its own six-monthly HIV prevention jabs by 2027. But there’s a hitch

None of the companies that will be involved have a licence from the inventor of Lenacapavir, Gilead Sciences, to make the jab

By Mia Malan
Building toilets, fighting TB: Candice Andisiwe Sehoma’s life of activism
Health
/ 22 October 2025

Building toilets, fighting TB: Candice Andisiwe Sehoma’s life of activism

From discontinued insulin pens to overpriced TB drugs, meet the young South African holding drug makers to account on behalf of patients

By Sean Christie
The six-monthly anti-HIV jab could be in 360 clinics by February. Who should get the first doses?
Health
/ 20 October 2025

The six-monthly anti-HIV jab could be in 360 clinics by February. Who should get the first doses?

The country’s medicines regulator Sahpra says it’s on track to announce its registration decision by the end of October

By Mia Malan
Botswana faces new HIV scare as shortage of medicines deepens
Africa
/ 20 October 2025

Botswana faces new HIV scare as shortage of medicines deepens

The Botswana Network on Ethics, Law and HIV/Aids says the crisis is not an isolated supply-chain issue but a ‘systemic failure’ that demands urgent government intervention

By Oarabile Mosikare
Clinics short-staffed after Pepfar funding cuts
Health
/ 19 October 2025

Clinics short-staffed after Pepfar funding cuts

According to a survey, 85% of managers reported that their clinics faced staffing shortages, though only one in five blamed these on the US President’s Emergency Plan For Aids Relief cuts

By Liezl Human
The six-monthly anti-HIV jab is coming. But can SA keep track of millions of users?
Health
/ 13 October 2025

The six-monthly anti-HIV jab is coming. But can SA keep track of millions of users?

The shot, called Lenacapavir, has a 100% success rate in preventing young women from getting HIV through sex

By Ida Jooste and Mia Malan
Two drugmakers will sell the 6-monthly anti-HIV jab for the price of the daily prevention pill
Health
/ 29 September 2025

Two drugmakers will sell the 6-monthly anti-HIV jab for the price of the daily prevention pill

Hetero and Dr Reddy’s will be funded by the Gates Foundation and Unitaid to produce and sell the twice-a-year anti-HIV shot around R692 per person a year

By Mia Malan
People living with HIV in fear as impact of donor funding cuts begin to show in eSwatini
Africa
/ 16 September 2025

People living with HIV in fear as impact of donor funding cuts begin to show in eSwatini

HIV prevention services have been heavily affected by the pause on the US President’s Emergency Plan for Aids in the country, with remote mobile clinics that served hard-to-reach people now closed

By UNAIDS
SA plans anti-HIV jab roll-out at hundreds of clinics by April
Health
/ 1 September 2025

SA plans anti-HIV jab roll-out at hundreds of clinics by April

The health department hopes to make the twice-a-year anti-HIV injection lenacapavir available soon and to be buying generics by 2027

By Mia Malan
At 16, he mediated a highjacking. Now he’s negotiating for the survival of HIV programmes
Health
/ 21 August 2025

At 16, he mediated a highjacking. Now he’s negotiating for the survival of HIV programmes

Ndiviwe Mphothulo, a medical doctor and president of the Southern African HIV Clinicians Society, is trying to make sure the Trump administration’s funding cuts don’t collapse South Africa’s HIV programmes

By Sean Christie
Most people on ARVs stay on them. Does our health system know that?
Health
/ 4 August 2025

Most people on ARVs stay on them. Does our health system know that?

The health department has R622 million extra to prop up South Africa’s HIV treatment programme in the wake of foreign aid cuts, but it’s only about a fifth of the total gap

By Linda Pretorius and Jacques Verryn
Small win for activists, but SA’s HIV projects won’t reopen
Health
/ 23 July 2025

Small win for activists, but SA’s HIV projects won’t reopen

The $400 million the United States congress removed from a list of funding programmes the Trump administration wants to cut doesn’t cancel the cuts to HIV and TB programmes made in February

By Mia Malan
Mozambican children die after US funding cuts: Who bears responsibility?
Africa
/ 21 July 2025

Mozambican children die after US funding cuts: Who bears responsibility?

The least the Trump administration could have done was provide ample warning that it was going to cut aid

By Jesse Copelyn
SA gets R520 million to buy the twice-a-year anti-HIV jab – but there’s a snag
Health
/ 16 July 2025

SA gets R520 million to buy the twice-a-year anti-HIV jab – but there’s a snag

The country isn’t getting extra money from the Global Fund to Fight Aids, TB and Malaria; it has to use cash from a grant it has already been awarded and was cut by 16% in June

By Mia Malan
HIV research: Professor screw it, let’s do it
Health
/ 30 June 2025

HIV research: Professor screw it, let’s do it

Francois Venter talks about his unorthodox inaugural lecture, his work during the Aids crisis and his shoot-from-the-hip fix of our healthcare system

By Sean Christie
National Health Insurance system will mean little if we don’t offer the right kind of care
Thought Leader
/ 24 June 2025

National Health Insurance system will mean little if we don’t offer the right kind of care

Although the NHI offers much-needed reform, it must find a new way to care for patients – an approach that treats people emotionally, physically, socially, psychologically and spiritually

By Shadrick Mazaza
Motsoaledi’s big HIV treatment jump: Is it true?
Health
/ 11 June 2025

Motsoaledi’s big HIV treatment jump: Is it true?

Last month, the health minister said more than half a million previously diagnosed people with HIV have been started on treatment since the end of February

By Linda Pretorius and Jacques Verryn
It’s the ‘Donald disease’ that’s making us sick
Health
/ 5 June 2025

It’s the ‘Donald disease’ that’s making us sick

With the 12 specialised key population clinics in South Africa funded by the US government, and now shuttered, getting treatment at government clinics has been difficult, if not impossible

By Tanya Pampalone and Mia Malan
Conventional and complementary healthcare professionals need to work together
Opinion
/ 31 May 2025

Conventional and complementary healthcare professionals need to work together

An inter-referral system between conventional and complementary medical practitioners is essential to giving patients optimal care in our diverse society

By Tebogo Tsele-Tebakang
A letter to the African Union and the continent’s governments
Thought Leader
/ 27 May 2025

A letter to the African Union and the continent’s governments

Aid dependency in the fight against HIV/Aids is not sustainable; Africa must own its health future. With political will, nothing is impossible

By Tuwilika Elias
The six-monthly anti-HIV jab could end Aids in SA by 2032
Health
/ 9 April 2025

The six-monthly anti-HIV jab could end Aids in SA by 2032

A modelling study released in March gives a clue at which price the jab, lenacapavir, would be worth the health department’s while

By Mia Malan
US aid cuts: Africa must make its own medicine
Thought Leader
/ 31 March 2025

US aid cuts: Africa must make its own medicine

Donald Trump’s funding freeze underlines that South Africa needs to prioritise the development of its pharmaceutical manufacturing sector

By Michael Mynhardt
The endgame to HIV/Aids
Thought Leader
/ 13 March 2025

The endgame to HIV/Aids

The United States’ shutdown of HIV/Aids funding may harm global Aids programmes irreparably, jeopardising millions of lives and putting HIV prevention at risk

By Seema Sengupta
No allocations for Pepfar in health budget
Business
/ 12 March 2025

No allocations for Pepfar in health budget

The recent termination of USAid to HIV/Aids and TB organisations in South Africa was a bone of contention in the 2025 budget

By Aarti Bhana
How Africa can recover from the disease of aid dependency
Thought Leader
/ 11 March 2025

How Africa can recover from the disease of aid dependency

In a changing world order, the continent must make urgent moves to wean itself off handouts

By Father Stan Muyebe
The Global Fund will roll out the twice-yearly anti-HIV jab — with or without Pepfar
Health
/ 5 March 2025

The Global Fund will roll out the twice-yearly anti-HIV jab — with or without Pepfar

In December, the Global Fund and the US President’s Emergency Plan for Aids Relief committed to funding the roll-out of lenacapavir in countries they support

By Ida Jooste
Trump’s funding cuts hit HIV, GBV services hard
Health
/ 15 February 2025

Trump’s funding cuts hit HIV, GBV services hard

The US president’s cutting of financial support has cut life-saving treatment for many in SA

By Umamah Bakharia
Some Pepfar projects can now restart in full, without a waiver
Health
/ 13 February 2025

Some Pepfar projects can now restart in full, without a waiver

A federal judge has enforced a temporary restraining order blocking Donald Trump from freezing federal grants

By Mia Malan
UPDATE | Embassy confirms Pepfar projects will restart, despite Trump aid ban
Health
/ 11 February 2025

UPDATE | Embassy confirms Pepfar projects will restart, despite Trump aid ban

Such programmes still qualify for a limited waiver, which will expire towards the end of April, but only for approved activities

By Mia Malan
Too little, too late: What a Pepfar waiver can’t do for HIV
Health
/ 3 February 2025

Too little, too late: What a Pepfar waiver can’t do for HIV

The US has said who qualifies for a waiver during the Trump administration’s pause in foreign aid but it doesn’t allow for anti-HIV pills, unless for pregnant women

By Mia Malan
HIV-Aids: South Africa’s journey and the road ahead
Opinion
/ 30 December 2024

HIV-Aids: South Africa’s journey and the road ahead

We need to tackle the inequality in society to overcome HIV-Aids — let’s take the rights path

By Solly Nduku
← Older posts

MAIL & GUARDIAN

ABOUT

About
Contact
Advertise

SUBSCRIPTIONS

Subscribe
Newsletters

FOLLOW

WhatsApp Channel
Twitter
Facebook
YouTube
Instagram
LinkedIn
TikTok
Threads

FLAGSHIP EVENTS

200 Young South Africans
Power Of Women
Greening The Future

LEGAL & CORRECTIONS

Privacy Policy
Cookie Policy
Ethics & Social Media Policy

RESOURCES

Mail & Guardian Careers
Property for sale


Mail & Guardian

© 2025 The Mail & Guardian. All rights reserved.

  • Login
  • Register
Forgot Password?
Lost your password? Please enter your username or email address. You will receive a link to create a new password via email.
body::-webkit-scrollbar { width: 7px; } body::-webkit-scrollbar-track { border-radius: 10px; background: #f0f0f0; } body::-webkit-scrollbar-thumb { border-radius: 50px; background: #dfdbdb }